Processing

Please wait...

Settings

Settings

Goto Application

1. WO2006119619 - OLIGONUCLEOTIDES INHIBITING CELL PROLIFERATION

Publication Number WO/2006/119619
Publication Date 16.11.2006
International Application No. PCT/CA2006/000735
International Filing Date 05.05.2006
IPC
A61K 47/48 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
48the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
A61K 31/7088 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
A61P 35/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61K 31/7088
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
A61K 47/59
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
50the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
51the non-active ingredient being a modifying agent
56the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
59obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • REPLICOR INC. [CA]/[CA] (AllExceptUS)
  • VAILLANT, Andrew [CA]/[CA] (UsOnly)
  • JUTEAU, Jean-Marc [CA]/[CA] (UsOnly)
Inventors
  • VAILLANT, Andrew
  • JUTEAU, Jean-Marc
Agents
  • OGILVY RENAULT LLP/S.E.N.C.R.L., S.R.L.
Priority Data
60/678,18306.05.2005US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) OLIGONUCLEOTIDES INHIBITING CELL PROLIFERATION
(FR) OLIGONUCLEOTIDES INHIBANT LA PROLIFERATION CELLULAIRE
Abstract
(EN) The present invention is concerned with the identification and use of encapsulated anti-cell proliferation oligonucleotides, with a delivery system, that act by a sequence independent mechanism. The present invention also disclosed the use of the oligonocleotides for the treatment of cancer and other cell proliferation related disease.
(FR) La présente invention concerne l’identification et l’utilisation d’oligonucléotides encapsulés contre la prolifération cellulaire, avec un système de délivrance, qui agit au moyen d’un mécanisme indépendant de la séquence. La présente invention décrit aussi l’utilisation des oligonucléotides pour le traitement du cancer et d’autres maladies liées à la prolifération cellulaire.
Related patent documents
EP6721889This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau